• Explore /
  • Poster
  • / Phase II study of panitumumab monotherapy in chemotherapy-naïve frail or elderly patients with unresectable, <em>RAS</em> wild type colorectal cancer: OGSG 1602, survival update data.

Phase II study of panitumumab monotherapy in chemotherapy-naïve frail or elderly patients with unresectable, RAS wild type colorectal cancer: OGSG 1602, survival update data.

Abstract Video & Slides Poster

Authors

null

Shingo Noura

Department of Surgery, Toyonaka Municipal Hospital, Toyonaka, Japan

Shingo Noura , Takeshi Kato , Tetsuji Terazawa , Masahiro Goto , Katsuya Ohta , Hironaga Satake , Yoshinori Kagawa , Hisato Kawakami , Hiroko Hasegawa , Kazuhiro Yanagihara , Tatsushi Shingai , Ken Nakata , Masahito Kotaka , Masayuki Hiraki , Ken Konishi , Shiro Nakae , Daisuke Sakai , Yukinori Kurokawa , Toshio Shimokawa , Taroh Satoh

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Advanced Disease

Clinical Trial Registration Number

UMIN000024528

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 3558)

DOI

10.1200/JCO.2021.39.15_suppl.3558

Abstract #

3558

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Katsuya Ohta

First Author: Matthew E. Burge

First Author: Kodai Takemori

First Author: Ramon Salazar